Literature DB >> 15704127

Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer.

Christoph Grunau1, Cecilia Sanchez, Melanie Ehrlich, Pierre van der Bruggen, Winfried Hindermann, Carmen Rodriguez, Sophie Krieger, Louis Dubeau, Emerich Fiala, Albertina De Sario.   

Abstract

The BAGE (B melanoma antigens) sequence family contains 15 nearly identical sequences that are in the juxtacentromeric regions of chromosomes 9, 13, 18, and 21. BAGE loci are expressed in male germ tissue and in a high percentage of cancers and cancer cell lines. We analyzed the DNA methylation state of the sequences in or near the promoters of the BAGE loci by a quantitative bisulfite and PCR-based assay (multiplex COBRA) using MboI and HphI in 18 somatic tissue samples, 4 testis and 4 sperm samples, and 48 tumors and tumor cell lines. In 94% of the control somatic tissue samples, DNA was highly methylated in the analyzed regions. In contrast, 98% of tumor DNA samples displayed hypomethylation. Also, DNA from testes and sperm was hypomethylated in at least one of the BAGE loci. BAGE transcripts were observed in only 47% of the analyzed tumor samples. Consequently, we propose BAGE hypomethylation as a new, highly informative epigenetic biomarker for the diagnosis of cancer, whose hypomethylation in cancer may be causally related to that of juxtacentromeric satellite DNA. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15704127     DOI: 10.1002/gcc.20155

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Mapping of the juxtacentromeric heterochromatin-euchromatin frontier of human chromosome 21.

Authors:  Christoph Grunau; Jérome Buard; Marie-Elisabeth Brun; Albertina De Sario
Journal:  Genome Res       Date:  2006-09-08       Impact factor: 9.043

Review 2.  Constitutive heterochromatin: a surprising variety of expressed sequences.

Authors:  Patrizio Dimitri; Ruggiero Caizzi; Ennio Giordano; Maria Carmela Accardo; Giovanna Lattanzi; Giuseppe Biamonti
Journal:  Chromosoma       Date:  2009-05-02       Impact factor: 4.316

Review 3.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

4.  DNA Methylation and Flavonoids in Genitourinary Cancers.

Authors:  Neelam Mukherjee; Addanki P Kumar; Rita Ghosh
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

5.  DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.

Authors:  Erica Lana; André Mégarbané; Hélène Tourrière; Pierre Sarda; Gérard Lefranc; Mireille Claustres; Albertina De Sario
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

Review 6.  Epigenetic diagnostics of cancer--the application of DNA methylation markers.

Authors:  Jaroslaw Paluszczak; Wanda Baer-Dubowska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

7.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.

Authors:  M Ehrlich; C B Woods; M C Yu; L Dubeau; F Yang; M Campan; D J Weisenberger; Ti Long; B Youn; E S Fiala; P W Laird
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

8.  Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Authors:  Luca Sigalotti; Alessia Covre; Elisabetta Fratta; Giulia Parisi; Francesca Colizzi; Aurora Rizzo; Riccardo Danielli; Hugues J M Nicolay; Sandra Coral; Michele Maio
Journal:  J Transl Med       Date:  2010-06-11       Impact factor: 5.531

Review 9.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

10.  Heterochromatic genes undergo epigenetic changes and escape silencing in immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome.

Authors:  Marie-Elisabeth Brun; Erica Lana; Isabelle Rivals; Gérard Lefranc; Pierre Sarda; Mireille Claustres; André Mégarbané; Albertina De Sario
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.